Article Versions Notes

Biswas P, Bibi S, Yousafi Q, Mehmood A, Saleem S, Ihsan A, Dey D, Hasan Zilani MN, Hasan MN, Saleem R, et al. Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach. Molecules. 2023; 28(7):2977. https://doi.org/10.3390/molecules28072977

Biswas, Partha, Shabana Bibi, Qudsia Yousafi, Asim Mehmood, Shahzad Saleem, Awais Ihsan, Dipta Dey, Md. Nazmul Hasan Zilani, Md. Nazmul Hasan, Rasha Saleem, and et al. 2023. "Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach" Molecules 28, no. 7: 2977. https://doi.org/10.3390/molecules28072977

Biswas, P., Bibi, S., Yousafi, Q., Mehmood, A., Saleem, S., Ihsan, A., Dey, D., Hasan Zilani, M. N., Hasan, M. N., Saleem, R., Awaji, A. A., Fahmy, U. A., & Abdel-Daim, M. M. (2023). Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach. Molecules, 28(7), 2977. https://doi.org/10.3390/molecules28072977